Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2868753/0/en/ALX-Oncology-Announces-Two-Evorpacept-Abstracts-Accepted-for-Poster-Presentation-at-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/09/2860415/0/en/ALX-Oncology-Reports-Encouraging-Clinical-Data-of-Evorpacept-in-Combination-with-Standard-of-Care-in-an-Ongoing-Phase-1-2-Clinical-Trial-in-Patients-with-Relapsed-or-Refractory-B-c.html
https://finance.yahoo.com/news/alx-oncology-elevated-valuation-analyst-204806187.html
https://www.globenewswire.com//news-release/2024/03/07/2842727/0/en/ALX-Oncology-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/03/05/2840941/0/en/ALX-Oncology-Announces-Two-Evorpacept-Clinical-Abstracts-Accepted-for-Presentation-at-the-AACR-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/01/03/2803258/0/en/ALX-Oncology-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/13/2779425/0/en/ALX-Oncology-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2023/11/01/2771702/0/en/ALX-Oncology-Announces-November-Investor-Conference-Participation.html
https://www.globenewswire.com//news-release/2023/10/10/2757900/0/en/ALX-Oncology-Announces-Closing-of-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
https://www.globenewswire.com//news-release/2023/10/05/2755329/0/en/ALX-Oncology-Announces-Pricing-of-Public-Offering.html